SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,314.59 -21.86
( -0.03%)

Global Indices

Nasdaq

51,493.09 -621.02
(-1.19%)

Dow Jones

7,573.47 -33.26
(-0.44%)

Hang Seng

63,960.24 37.24
(0.06%)

Nikkei 225

10,816.25 127.78
(1.20%)

Forex

USD-INR

95.42 0.14
(0.14%)

EUR-INR

110.10 0.01
(0.01%)

GBP-INR

128.62 0.03
(0.02%)

JPY-INR

0.62 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indoco Remedies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532612

INE873D01024

119.0843544

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INDOCO

108.93

2342.67

EPS(TTM)

Face Value()

Div & Yield %

2.33

0.08

Back

Indo Rama Synthetics (India) consolidated net profit rises 20.83% in the June 2026 quarter

Jul 29,2026

Net profit of Indo Rama Synthetics (India) rose 20.83% to Rs 63.74 crore in the quarter ended June 2026 as against Rs 52.75 crore during the previous quarter ended June 2025. Sales declined 28.27% to Rs 936.64 crore in the quarter ended June 2026 as against Rs 1305.71 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	936.64	1305.71	-28
OPM %	10.84	6.96	-
PBDT	75.75	64.68	17
PBT	63.74	52.75	21
NP	63.74	52.75	21

74,314.59 -21.86 ( -0.03%)

51,493.09 -621.02 (-1.19%)

7,573.47 -33.26 (-0.44%)

63,960.24 37.24 (0.06%)

10,816.25 127.78 (1.20%)

95.42 0.14 (0.14%)

110.10 0.01 (0.01%)

128.62 0.03 (0.02%)

0.62 0.00 (-0.26%)